These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10050727)

  • 1. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas.
    Sebestyén A; Berczi L; Mihalik R; Paku S; Matolcsy A; Kopper L
    Br J Haematol; 1999 Feb; 104(2):412-9. PubMed ID: 10050727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells--an immuno electron microscopic study.
    Seftalioglu A; Karakus S; Dundar S; Can B; Erdemli E; Irmak MK; Oztas E; Korkmaz C; Yazar F; Cavusoglu I
    Acta Oncol; 2003; 42(1):71-4. PubMed ID: 12665334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
    Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
    Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
    Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
    Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-1 in B lymphoid malignancies.
    Sanderson RD; Børset M
    Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.
    Costes V; Magen V; Legouffe E; Durand L; Baldet P; Rossi JF; Klein B; Brochier J
    Hum Pathol; 1999 Dec; 30(12):1405-11. PubMed ID: 10667416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
    O'Connell FP; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells.
    Gattei V; Godeas C; Degan M; Rossi FM; Aldinucci D; Pinto A
    Br J Haematol; 1999 Jan; 104(1):152-62. PubMed ID: 10027728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecans and the lymphoid system.
    Kopper L; Sebestyén A
    Leuk Lymphoma; 2000 Jul; 38(3-4):271-81. PubMed ID: 10830734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYNDECAN-1 (CD138) expression in human non-Hodgkin's lymphomas.
    Sutcliffe M; Oscier D; Wright DH
    Br J Haematol; 2000 Jul; 110(1):239-40. PubMed ID: 10931010
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas.
    Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC
    Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
    Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
    J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
    Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
    J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of syndecans in lymphoid systems].
    Sebestyén A; Kopper L
    Magy Onkol; 2001; 45(1):67-74. PubMed ID: 12050731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
    Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
    Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1/CD138 expression in normal myeloid, acute lymphoblastic and myeloblastic leukemia cells.
    Seftalioglu A; Karakus S
    Acta Histochem; 2003; 105(3):213-21. PubMed ID: 13677614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
    Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
    Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment.
    Dhodapkar MV; Sanderson RD
    Leuk Lymphoma; 1999 Jun; 34(1-2):35-43. PubMed ID: 10350330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia.
    Sebestyén A; Kovalszky I; Mihalik R; Gallai M; Bocsi J; László E; Benedek S; Sréter L; Kopper L
    Eur J Cancer; 1997 Nov; 33(13):2273-7. PubMed ID: 9470818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.